4-methyl-3-[3-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-1H-indazol-6-yl]-N-[3-(trifluoromethyl)phenyl]benzamide
C31H29F3N6O2 — CID 155557936
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-methyl-3-[3-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-1H-indazol-6-yl]-N-[3-(trifluoromethyl)phenyl]benzamide
4-methyl-3-[3-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-1H-indazol-6-yl]-N-[3-(trifluoromethyl)phenyl]benzamide (PubChem CID 155557936) has the molecular formula C31H29F3N6O2 and a molecular weight of 574.61 g/mol. Its IUPAC name is 4-methyl-3-[3-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-1H-indazol-6-yl]-N-[3-(trifluoromethyl)phenyl]benzamide.
Molecular Properties
| Compound Name | 4-methyl-3-[3-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-1H-indazol-6-yl]-N-[3-(trifluoromethyl)phenyl]benzamide |
|---|---|
| PubChem CID | 155557936 |
| Molecular Formula | C31H29F3N6O2 |
| Molecular Weight | 574.61 g/mol |
| Exact Mass | 574.23 |
| IUPAC Name | 4-methyl-3-[3-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-1H-indazol-6-yl]-N-[3-(trifluoromethyl)phenyl]benzamide |
| SMILES | Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(CCN4CCOCC4)c3)n[nH]c2c1 |
| InChI | InChI=1S/C31H29F3N6O2/c1-20-5-6-22(30(41)36-25-4-2-3-24(17-25)31(32,33)34)15-27(20)21-7-8-26-28(16-21)37-38-29(26)23-18-35-40(19-23)10-9-39-11-13-42-14-12-39/h2-8,15-19H,9-14H2,1H3,(H,36,41)(H,37,38) |
| InChIKey | JJQCGTDHNYRBRY-UHFFFAOYSA-N |
| XLogP | 6.01 |
| TPSA | 88.07 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 42 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 574.61 |
| LogP ≤ 5 | 6.01 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155557936 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.